{"Symbol": "LXRX", "AssetType": "Common Stock", "Name": "Lexicon Pharmaceuticals, Inc", "Description": "Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the treatment of type 1 and is in Phase III clinical trials for the treatment of type 2 diabetes; LX9211, which is in Phase I clinical development for the treatment of neuropathic pain; and LX2761 that is in Phase I clinical development for the treatment of diabetes. The company has strategic collaboration and license agreements with Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "8800 Technology Forest Place, The Woodlands, TX, United States, 77381-1160", "FullTimeEmployees": "184", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "186364448", "EBITDA": "82529000", "PERatio": "5.7419", "PEGRatio": "-0.14", "BookValue": "0.512", "DividendPerShare": "None", "DividendYield": "0", "EPS": "0.369", "RevenuePerShareTTM": "3.007", "ProfitMargin": "0.1226", "OperatingMarginTTM": "0.2519", "ReturnOnAssetsTTM": "0.1815", "ReturnOnEquityTTM": "18.7721", "RevenueTTM": "320336992", "GrossProfitTTM": "226918000", "DilutedEPSTTM": "0.369", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.054", "AnalystTargetPrice": "2.7", "TrailingPE": "5.7419", "ForwardPE": "0", "PriceToSalesRatioTTM": "0.6505", "PriceToBookRatio": "3.6908", "EVToRevenue": "0.7324", "EVToEBITDA": "4.0763", "Beta": "1.1022", "52WeekHigh": "5.33", "52WeekLow": "1.22", "50DayMovingAverage": "1.875", "200DayMovingAverage": "2.0593", "SharesOutstanding": "107106000", "SharesFloat": "41102942", "SharesShort": "10397043", "SharesShortPriorMonth": "10919216", "ShortRatio": "4.73", "ShortPercentOutstanding": "0.14", "ShortPercentFloat": "0.5191", "PercentInsiders": "5.227", "PercentInstitutions": "101.478", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "1:7", "LastSplitDate": "2015-05-21"}